| BF n = 62/81 | non-BF n = 19/81 | p |
OGTT 0 | 90.1 ± 16.4 | 92.2 ± 8.9 | 0.61 |
OGTT 30 | 142.5 ± 34.3 | 140.1 ± 40.1 | 0.82 |
OGTT 60 | 140.7 ± 42.4 | 124.0 ± 33.0 | 0.16 |
OGTT 90 | 113.6 ± 36.8 | 107.0 ± 32.1 | 0.54 |
OGTT 120 | 101.5 ± 28.1 | 101.2 ± 26.9 | 0.97 |
OGTT alteration (%) DM/IFG/IGT (n˚) | 29 7 DM, 5 IFG, 6 IGT | 31.6 1 DM, 4 IFG, 1 IFG/IGT | 0.34 |
Homa-IR | 2.2 ± 3.9 | 2.7 ± 2.7 | 0.64 |
ISI | 8.1 ± 4.2 | 6.8 ± 3.6 | 0.34 |
Homa-IS | 1.0 ± 0.7 | 0.6 ± 0.4 | 0.04 |
Insulinogenic index | 14.1 ± 14.0 | 11.7 ± 29.9 | 0.68 |
AUCIRI/AUCBG | 0.3 ± 0.2 | 0.4 ± 0.2 | 0.80 |
Disposition index | 2.5 ± 1.08 | 1.96 ± 0.62 | 0.78 |
Cholesterol (mg/dl) | 191.9 ± 37.7 | 203.4 ± 40 | 0.31 |
HDL (mg/dl) | 55.9 ± 14.7 | 55.7 ± 15.4; | 0.95 |
LDL (mg/dl) | 116.3 ± 40.7 | 120.3 ± 29.6 | 0.76 |
Triglycerides (mg/dl) | 83.8 ± 46.7 | 123.2 ± 94.0 | 0.03 Mann-Whitney |
ApoA1 (mg/dl) | 147.6 ± 22.9 | 150 ± 37.9 | 0.79 |
ApoB (mg/dl) | 93.13 ± 25.8 | 106.8 ± 23.6 | 0.13 |
ApoB/ApoA1 | 0.65 ± 0.23 | 0.73 ± 0.16 | 0.31 |
hs-CRP (mg/L) | 0.5 ± 0.7 | 2.3 ± 6.2 | 0.08 |
Homocysteine (µmoli/L) | 8.6 ± 3.2 | 7.9 ± 2.3 | 0.52 |
Systolic (mmHg) | 112.17 ± 15.7 | 110 ± 11.9 | 0.66 |
Diastolic (mmHg) | 71.6 ± 10.6 | 72.6 ± 9.2 | 0.73 |
MS/ATPIII (%) | 50.0 | 27.7 | 0.67 |